GALECTIN THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
GALECTIN THERAPEUTICS INC. (GALT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 211.58 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-14
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 211.58K shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 225.75K shares.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 403.08K shares, a 15.58% increase from fiscal 2024.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 348.75K shares, a 20.14% decline from fiscal 2023.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 436.72K shares, a 98.51% increase from fiscal 2022.
- GALECTIN THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 220.00K shares, a 86.28% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 211.58K shares 10-Q · filed 2026-08-14 | 437.33K shares derived: sum of 3 quarters · filed 2026-08-14 | 437.33K shares derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | 211.58K shares 10-Q · filed 2026-05-15 | 437.33K shares derived: sum of 2 quarters · filed 2026-05-15 | 437.33K shares derived: sum of 3 quarters · filed 2026-05-15 | ||
| 2025-12-31 | 225.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 225.75K shares derived: sum of 2 quarters · filed 2026-03-31 | 403.08K shares 10-K · filed 2026-03-31 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 177.33K shares 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 177.33K shares 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 119.17K shares derived: sum of 2 quarters · filed 2026-03-31 | 211.25K shares derived: sum of 3 quarters · filed 2026-03-31 | 348.75K shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 119.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 211.25K shares derived: sum of 2 quarters · filed 2024-11-14 | 348.75K shares 10-Q · filed 2024-11-14 | 441.67K shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-06-30 | 92.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 229.58K shares 10-Q · filed 2024-08-13 | 322.50K shares derived: sum of 3 quarters · filed 2025-03-31 | 407.50K shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-03-31 | 137.50K shares 10-Q · filed 2024-05-15 | 230.42K shares derived: sum of 2 quarters · filed 2025-03-31 | 315.42K shares derived: sum of 3 quarters · filed 2025-03-31 | 555.42K shares derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | 92.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 177.92K shares derived: sum of 2 quarters · filed 2025-03-31 | 417.92K shares derived: sum of 3 quarters · filed 2025-03-31 | 436.72K shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 85.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 325.00K shares derived: sum of 2 quarters · filed 2023-11-13 | 343.80K shares 10-Q · filed 2023-11-13 | 368.80K shares derived: sum of 4 quarters · filed 2024-03-29 | |
| 2023-06-30 | 240.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 258.80K shares 10-Q · filed 2023-08-14 | 283.80K shares derived: sum of 3 quarters · filed 2024-03-29 | 283.80K shares derived: sum of 4 quarters · filed 2024-03-29 | |
| 2023-03-31 | 18.80K shares 10-Q · filed 2023-05-15 | 43.80K shares derived: sum of 2 quarters · filed 2024-03-29 | 43.80K shares derived: sum of 3 quarters · filed 2024-03-29 | 228.80K shares derived: sum of 4 quarters · filed 2024-03-29 | |
| 2022-12-31 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 25.00K shares derived: sum of 2 quarters · filed 2024-03-29 | 210.00K shares derived: sum of 3 quarters · filed 2024-03-29 | 220.00K shares 10-K · filed 2024-03-29 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 185.00K shares derived: sum of 2 quarters · filed 2022-11-14 | 195.00K shares 10-Q · filed 2022-11-14 | 607.72K shares derived: sum of 4 quarters · filed 2023-03-30 | |
| 2022-06-30 | 185.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 195.00K shares 10-Q · filed 2022-08-15 | 607.72K shares derived: sum of 3 quarters · filed 2023-03-30 | 917.72K shares derived: sum of 4 quarters · filed 2023-03-30 | |
| 2022-03-31 | 10.00K shares 10-Q · filed 2022-05-16 | 422.72K shares derived: sum of 2 quarters · filed 2023-03-30 | 732.72K shares derived: sum of 3 quarters · filed 2023-03-30 | 1.59M shares derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-12-31 | 412.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 722.72K shares derived: sum of 2 quarters · filed 2023-03-30 | 1.58M shares derived: sum of 3 quarters · filed 2023-03-30 | 1.60M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 310.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 1.17M shares derived: sum of 2 quarters · filed 2021-11-15 | 1.19M shares 10-Q · filed 2021-11-15 | 1.19M shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2021-06-30 | 860.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 880.35K shares 10-Q · filed 2021-08-16 | 880.35K shares derived: sum of 3 quarters · filed 2022-03-31 | 880.35K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2021-03-31 | 20.00K shares 10-Q · filed 2021-05-17 | 20.00K shares derived: sum of 2 quarters · filed 2022-03-31 | 20.00K shares derived: sum of 3 quarters · filed 2022-03-31 | 20.00K shares derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-31 | 23.06K shares 10-K · filed 2022-03-31 | 834.00 shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-09 | 23.06K shares 10-Q · filed 2020-11-09 | 76.69K shares derived: sum of 4 quarters · filed 2021-03-31 | |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 23.06K shares 10-Q · filed 2020-08-10 | 76.69K shares derived: sum of 3 quarters · filed 2021-03-31 | 76.69K shares derived: sum of 4 quarters · filed 2021-03-31 | |
| 2020-03-31 | 23.06K shares 10-Q · filed 2020-05-11 | 76.69K shares derived: sum of 2 quarters · filed 2021-03-31 | 76.69K shares derived: sum of 3 quarters · filed 2021-03-31 | 76.69K shares derived: sum of 4 quarters · filed 2021-03-31 | |
| 2019-12-31 | 53.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 53.63K shares derived: sum of 2 quarters · filed 2021-03-31 | 53.63K shares derived: sum of 3 quarters · filed 2021-03-31 | 92.73K shares 10-K · filed 2021-03-31 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-12 | 39.10K shares 10-Q · filed 2019-11-12 | 1.18M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 39.10K shares 10-Q · filed 2019-08-09 | 1.18M shares derived: sum of 3 quarters · filed 2020-03-16 | 1.36M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-03-31 | 39.10K shares 10-Q · filed 2019-05-10 | 1.18M shares derived: sum of 2 quarters · filed 2020-03-16 | 1.36M shares derived: sum of 3 quarters · filed 2020-03-16 | 1.39M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-12-31 | 1.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 1.32M shares derived: sum of 2 quarters · filed 2020-03-16 | 1.35M shares derived: sum of 3 quarters · filed 2020-03-16 | 1.35M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 175.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 209.12K shares derived: sum of 2 quarters · filed 2018-11-13 | 209.12K shares 10-Q · filed 2018-11-13 | 209.12K shares derived: sum of 4 quarters · filed 2019-03-06 | |
| 2018-06-30 | 33.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 33.33K shares 10-Q · filed 2018-08-14 | 33.33K shares derived: sum of 3 quarters · filed 2019-03-06 | 33.33K shares derived: sum of 4 quarters · filed 2019-03-06 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-06 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-06 | 0.00 shares derived: sum of 4 quarters · filed 2019-03-06 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-06 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-06 | 0.00 shares 10-K · filed 2019-03-06 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-07 | 0.00 shares 10-Q · filed 2017-11-07 | 0.00 shares derived: sum of 4 quarters · filed 2018-03-29 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 0.00 shares 10-Q · filed 2017-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2018-03-29 | 0.00 shares derived: sum of 4 quarters · filed 2018-03-29 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-29 | 0.00 shares derived: sum of 3 quarters · filed 2018-03-29 | 101.67K shares derived: sum of 4 quarters · filed 2018-03-29 | |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-29 | 101.67K shares derived: sum of 3 quarters · filed 2018-03-29 | 120.19K shares 10-K · filed 2018-03-29 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 101.67K shares derived: sum of 2 quarters · filed 2016-11-08 | 120.19K shares 10-Q · filed 2016-11-08 | 120.19K shares derived: sum of 4 quarters · filed 2017-03-28 | |
| 2016-06-30 | 101.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 120.19K shares 10-Q · filed 2016-08-09 | 120.19K shares derived: sum of 3 quarters · filed 2017-03-28 | 120.19K shares derived: sum of 4 quarters · filed 2017-03-28 | |
| 2016-03-31 | 18.52K shares 10-Q · filed 2016-05-10 | 18.52K shares derived: sum of 2 quarters · filed 2017-03-28 | 18.52K shares derived: sum of 3 quarters · filed 2017-03-28 | 245.93K shares derived: sum of 4 quarters · filed 2017-03-28 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-28 | 227.41K shares derived: sum of 3 quarters · filed 2017-03-28 | 348.72K shares 10-K · filed 2017-03-28 | |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 227.41K shares derived: sum of 2 quarters · filed 2015-11-09 | 348.72K shares 10-Q · filed 2015-11-09 | 448.90K shares derived: sum of 4 quarters · filed 2016-03-15 | |
| 2015-06-30 | 227.41K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 348.72K shares 10-Q · filed 2015-08-10 | 448.90K shares derived: sum of 3 quarters · filed 2016-03-15 | 451.09K shares derived: sum of 4 quarters · filed 2016-03-15 | |
| 2015-03-31 | 121.31K shares 10-Q · filed 2015-05-11 | 221.49K shares derived: sum of 2 quarters · filed 2016-03-15 | 223.68K shares derived: sum of 3 quarters · filed 2016-03-15 | 224.52K shares derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-12-31 | 100.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 102.38K shares derived: sum of 2 quarters · filed 2016-03-15 | 103.21K shares derived: sum of 3 quarters · filed 2016-03-15 | 124.47K shares 10-K · filed 2016-03-15 | |
| 2014-09-30 | 2.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 3.02K shares derived: sum of 2 quarters · filed 2014-11-10 | 24.28K shares 10-Q · filed 2014-11-10 | 125.92K shares derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-06-30 | 833.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 22.09K shares 10-Q · filed 2014-08-07 | 123.72K shares derived: sum of 3 quarters · filed 2016-03-15 | 315.81K shares derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-03-31 | 21.26K shares 10-Q · filed 2014-05-13 | 122.89K shares derived: sum of 2 quarters · filed 2016-03-15 | 314.98K shares derived: sum of 3 quarters · filed 2016-03-15 | 380.52K shares derived: sum of 4 quarters · filed 2016-03-15 | |
| 2013-12-31 | 101.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 293.72K shares derived: sum of 2 quarters · filed 2016-03-15 | 359.27K shares derived: sum of 3 quarters · filed 2016-03-15 | 403.67K shares 10-K · filed 2016-03-15 | |
| 2013-09-30 | 192.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 257.63K shares derived: sum of 2 quarters · filed 2013-11-12 | 302.04K shares 10-Q · filed 2013-11-12 | 373.71K shares derived: sum of 4 quarters · filed 2015-03-18 | |
| 2013-06-30 | 65.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 109.95K shares 10-Q · filed 2013-08-14 | 181.62K shares derived: sum of 3 quarters · filed 2015-03-18 | 181.62K shares derived: sum of 4 quarters · filed 2015-03-18 | |
| 2013-03-31 | 44.41K shares 10-Q · filed 2013-05-10 | 116.08K shares derived: sum of 2 quarters · filed 2015-03-18 | 116.08K shares derived: sum of 3 quarters · filed 2015-03-18 | ||
| 2012-12-31 | 71.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | 71.67K shares derived: sum of 2 quarters · filed 2015-03-18 | 299.68K shares 10-K · filed 2015-03-18 | ||
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 228.01K shares 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | 228.01K shares 10-Q · filed 2012-08-10 | ||||
| 2011-12-31 | 334.54K shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |